The abnormal accumulation of antibody-producing immune cells in the lungs may contribute to IPF progression, a new study ...

Blocking Piezo2, a protein receptor that senses mechanical forces in tissues, may be a new way to slow IPF progression, per a ...

Columnist Sam Kirton invites readers to join him on the way to the Pulmonary Fibrosis News Forums, where he's a moderator.

Columnist Ann Reynoso was worried before a recent bronchoscopy, but her medical team's excellent bedside manner put her mind at ease.

For National Donate Life Month, columnist Sam Kirton urges readers to spread the word about the importance of being an organ donor.

Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating its idiopathic pulmonary fibrosis (IPF) treatment bexotegrast due to safety issues. The BEACON-IPF (NCT06097260) ...

Weight loss is a recurring topic during my medical appointments, and I frequently discuss it with my transplant team. I wrote about this a couple years ago in a column titled “Using Ozempic in hopes ...

Basal stem cells taken from the upper part of a patient’s respiratory tract can be expanded in the lab and then transplanted back into their lungs to treat idiopathic pulmonary fibrosis (IPF), ...

Columnist Sam Kirton and his wife go with the flow when changes are necessary, such as rescheduling a Halloween party to the advent of spring.